Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 125

1.

Mast Cell Degranulation Exacerbates Skin Rejection by Enhancing Neutrophil Recruitment.

Ngo Nyekel F, Pacreau E, Benadda S, Msallam R, Åbrink M, Pejler G, Davoust J, Benhamou M, Charles N, Launay P, Blank U, Gautier G.

Front Immunol. 2018 Nov 20;9:2690. doi: 10.3389/fimmu.2018.02690. eCollection 2018.

2.

Sugar-Sweetened Beverage Attitudes and Consumption During the First 1000 Days of Life.

Woo Baidal JA, Morel K, Nichols K, Elbel E, Charles N, Goldsmith J, Chen L, Taveras E.

Am J Public Health. 2018 Dec;108(12):1659-1665. doi: 10.2105/AJPH.2018.304691. Epub 2018 Oct 25.

PMID:
30359102
3.

Multicentred randomised controlled trial of an augmented exercise referral scheme using web-based behavioural support in individuals with metabolic, musculoskeletal and mental health conditions: protocol for the e-coachER trial.

Ingram W, Webb D, Taylor RS, Anokye N, Yardley L, Jolly K, Mutrie N, Campbell JL, Dean SG, Greaves C, Steele M, Lambert JD, McAdam C, Jane B, King J, Jones RB, Little P, Woolf A, Erwin J, Charles N, Terry RH, Taylor AH; Trial Steering Committee.

BMJ Open. 2018 Sep 21;8(9):e022382. doi: 10.1136/bmjopen-2018-022382.

4.

Tomosyn functions as a PKCδ-regulated fusion clamp in mast cell degranulation.

Madera-Salcedo IK, Danelli L, Tiwari N, Dema B, Pacreau E, Vibhushan S, Birnbaum J, Agabriel C, Liabeuf V, Klingebiel C, Menasche G, Macias-Silva M, Benhamou M, Charles N, González-Espinosa C, Vitte J, Blank U.

Sci Signal. 2018 Jul 3;11(537). pii: eaan4350. doi: 10.1126/scisignal.aan4350.

PMID:
29970602
5.

Prostaglandin D2 amplifies lupus disease through basophil accumulation in lymphoid organs.

Pellefigues C, Dema B, Lamri Y, Saidoune F, Chavarot N, Lohéac C, Pacreau E, Dussiot M, Bidault C, Marquet F, Jablonski M, Chemouny JM, Jouan F, Dossier A, Chauveheid MP, Gobert D, Papo T, Karasuyama H, Sacré K, Daugas E, Charles N.

Nat Commun. 2018 Feb 20;9(1):725. doi: 10.1038/s41467-018-03129-8.

6.

Non-IgE mediated mast cell activation.

Redegeld FA, Yu Y, Kumari S, Charles N, Blank U.

Immunol Rev. 2018 Mar;282(1):87-113. doi: 10.1111/imr.12629. Review.

PMID:
29431205
7.

IgE in lupus pathogenesis: Friends or foes?

Augusto JF, Truchetet ME, Charles N, Blanco P, Richez C.

Autoimmun Rev. 2018 Apr;17(4):361-365. doi: 10.1016/j.autrev.2017.11.027. Epub 2018 Feb 7. Review.

PMID:
29425937
8.

A-Site Ordered Double Perovskite CaMnTi2O6 as a Multifunctional Piezoelectric and Ferroelectric-Photovoltaic Material.

Gou G, Charles N, Shi J, Rondinelli JM.

Inorg Chem. 2017 Oct 2;56(19):11854-11861. doi: 10.1021/acs.inorgchem.7b01854. Epub 2017 Sep 11.

PMID:
28891640
9.

Lyn and Fyn function as molecular switches that control immunoreceptors to direct homeostasis or inflammation.

Mkaddem SB, Murua A, Flament H, Titeca-Beauport D, Bounaix C, Danelli L, Launay P, Benhamou M, Blank U, Daugas E, Charles N, Monteiro RC.

Nat Commun. 2017 Aug 15;8(1):246. doi: 10.1038/s41467-017-00294-0.

10.

Basophils contribute to pristane-induced Lupus-like nephritis model.

Dema B, Lamri Y, Pellefigues C, Pacreau E, Saidoune F, Bidault C, Karasuyama H, Sacré K, Daugas E, Charles N.

Sci Rep. 2017 Aug 11;7(1):7969. doi: 10.1038/s41598-017-08516-7.

11.

Recurrent profuse hemorrhage after chalazion excision in a patient with systemic amyloidosis.

Khandji J, Shah P, Charles N, Patel P.

Can J Ophthalmol. 2017 Aug;52(4):e136-e138. doi: 10.1016/j.jcjo.2017.01.019. Epub 2017 Mar 16. No abstract available.

PMID:
28774538
12.

Development and evaluation of a leaflet for concerned family members and friends: 'It's safe to talk about suicide'.

Owens C, Charles N.

Health Educ J. 2017 Aug;76(5):582-594. doi: 10.1177/0017896917706601. Epub 2017 May 23.

13.

Phospholipid scramblase 1 amplifies anaphylactic reactions in vivo.

Kassas-Guediri A, Coudrat J, Pacreau E, Launay P, Monteiro RC, Blank U, Charles N, Benhamou M.

PLoS One. 2017 Mar 10;12(3):e0173815. doi: 10.1371/journal.pone.0173815. eCollection 2017.

14.

Early Phase Mast Cell Activation Determines the Chronic Outcome of Renal Ischemia-Reperfusion Injury.

Danelli L, Madjene LC, Madera-Salcedo I, Gautier G, Pacreau E, Ben Mkaddem S, Charles N, Daugas E, Launay P, Blank U.

J Immunol. 2017 Mar 15;198(6):2374-2382. doi: 10.4049/jimmunol.1601282. Epub 2017 Feb 6.

15.

Holding Resilience in Trust: Working Systemically With Families Following an Acquired Brain Injury.

Butera-Prinzi F, Charles N, Story K.

J Soc Work Disabil Rehabil. 2016 Aug 11:1-20. [Epub ahead of print]

PMID:
27618587
16.

Is renal medullary carcinoma the seventh nephropathy in sickle cell disease? A multi-center Nigerian survey.

Anazoeze M, Najibah G, Garba U, Shehu A, Florence F, Abdulaziz H, Marcus I, Oluwaseun A, Theresa N, Obike I, Sunday O, Ifeoma E, Anthony I, Barth C, Chide O, Joseph O, Malachy I, Kaladada K, Uche A, Kingsley A, Charles N, Angela U, Augustin D, Chikwudi A, Alozie E, Uchenna O, Caroline O, Obineche A, Iheanyi O.

Afr Health Sci. 2016 Jun;16(2):490-6. doi: 10.4314/ahs.v16i2.17.

17.

Reconstructive Transitions from Rotations of Rigid Heteroanionic Polyhedra.

Holland M, Charles N, Rondinelli JM, Poeppelmeier KR.

J Am Chem Soc. 2016 Sep 14;138(36):11882-9. doi: 10.1021/jacs.6b06813. Epub 2016 Aug 30.

PMID:
27532822
18.

Implementation of a text-messaging intervention for adolescents who self-harm (TeenTEXT): a feasibility study using normalisation process theory.

Owens C, Charles N.

Child Adolesc Psychiatry Ment Health. 2016 Jun 28;10:14. doi: 10.1186/s13034-016-0101-z. eCollection 2016.

19.

Identification of Biological and Pharmaceutical Mast Cell- and Basophil-Related Targets.

Klein O, Ngo-Nyekel F, Stefanache T, Torres R, Salomonsson M, Hallgren J, Rådinger M, Bambouskova M, Campbell M, Cohen-Mor S, Dema B, Rose CG, Abrink M, Charles N, Ainooson G, Paivandy A, Pavlova VG, Serrano-Candelas E, Yu Y, Hellman L, Jensen BM, Van Anrooij B, Grootens J, Gura HK, Stylianou M, Tobio A, Blank U, Öhrvik H, Maurer M.

Scand J Immunol. 2016 Jun;83(6):465-72. doi: 10.1111/sji.12436. No abstract available.

20.

What Should Be the Treatment Protocol in Cases of Second and Third Degree Hemorrhoids?

Lunawat A, Charles N, Ranjan V.

Indian J Surg. 2015 Dec;77(Suppl 3):1493. doi: 10.1007/s12262-014-1097-3. Epub 2014 May 10. No abstract available.

Supplemental Content

Loading ...
Support Center